Medical Facilities Corporation

TSX:DR.TO

Medical - Care Facilities

Healthcare
$17.42 +1.01%

+$0.18 today

Market cap
$282.43M
Beta
0.34
P/E (TTM)
8.7
EPS (TTM)
$1.47
Dividend yield
2.00%
52W Low $13.59High $18.79

Volume 0.02M

Average 0.02M

DR.TO Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

Medical Facilities CorporationTSX: DR.TO

{ "id": "headlineRatioNarrows", "params": { "amount": { "type": "amount", "value": 0.38144835911264313 } } }

[ { "id": "ratioLevelDown", "params": { "amount": { "type": "amount", "value": 0.38144835911264313 }, "period": { "type": "period", "period": { "kind": "quarter", "fiscalYear": 2026, "fiscalQuarter": 1 } }, "change": { "type": "change", "value": 28.2330185567583 } } }, { "id": "ratioTtmDown", "params": { "amount": { "type": "amount", "value": 0.4454137122446358 }, "change": { "type": "change", "value": 21.262192885246733 } } }, { "id": "longRunNarrowed", "params": { "years": { "type": "count", "value": 3 }, "change": { "type": "change", "value": 28.129019298470247 } } } ]

Context

  • { "id": "streakWidened", "params": { "rises": { "type": "count", "value": 1 }, "years": { "type": "count", "value": 3 } }, "count": 3 }
  • { "id": "extremeLowestLevel", "params": { "fiscalYear": { "type": "fiscalYear", "value": 2025 }, "years": { "type": "count", "value": 4 } } }

Sources:Income StatementText generated from reported figures; not investment advice.

Mar 2026
38.1%-2.4 pp
Dec 2025
38.0%-28.4 pp
Mar 2026
44.5%-21.3 pp
Gross Margin past and forecast change by horizon
Horizon Past Forecast Difference
-28.2 pp——
-28.4 pp——
-28.1 pp——
——
——

Gross Margin history

Percent of revenue · from the income statement

Latest · FY2025
38.0%
Year-over-year change
-28.4pp

Gross Margin vs competitors

How DR.TO compares with its peers on the latest reported figures

  • { "id": "valueRankMedian", "params": { "ticker": { "type": "text", "value": "DR.TO" }, "period": { "type": "peerPeriod", "period": { "kind": "ltm", "date": "2026-03-31" } }, "amount": { "type": "amount", "value": 0.4454137122446358 }, "rank": { "type": "rank", "position": 5, "total": 8, "direction": "high", "bySize": false }, "count": { "type": "count", "value": 8 }, "median": { "type": "amount", "value": 0.4754802416659309 } } }
  • { "id": "yoyRankMedian", "params": { "change": { "type": "signedChange", "value": -21.262192885246733 }, "rank": { "type": "rank", "position": 7, "total": 8, "direction": "high", "bySize": false }, "count": { "type": "count", "value": 8 }, "median": { "type": "signedChange", "value": -3.0537094769966746 } } }
  • { "id": "threeYearChange", "params": { "change": { "type": "signedChange", "value": -28.129019298470247 }, "median": { "type": "signedChange", "value": 12.998803238922545 } } }
DR.TO Competitors Peer median
Gross Margin for DR.TO and competitors
Company Period YoY 3-year change
FRX.TOFennec Pharmaceuticals Inc.—92.2% +1.9 pp-2.8 pp
PRN.TOProfound Medical Corp.—71.0% +4.1 pp+25.6 pp
TSND.TOTerrAscend Corp.—50.9% -0.7 pp+0.4 pp
XLY.TOAuxly Cannabis Group Inc.—47.5% -5.8 pp+39.8 pp
DR.TOMedical Facilities Corporation—44.5% -21.3 pp-28.1 pp
CRRX.TOCareRx Corporation—26.5% -3.1 pp-3.8 pp
WEED.TOCanopy Growth Corporation—23.6% -5.9 pp+54.0 pp
OGI.TOOrganiGram Holdings Inc.—-3.1% -35.8 pp—
EPRX.TOEupraxia Pharmaceuticals Inc.—— ——
Peer median (excluding DR.TO) 47.5%-3.1 pp+13.0 pp

Competitors are the stored peer set for DR.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY 2021
Dec 2021
FY 2022
Dec 2022
FY 2023
Dec 2023
FY 2024
Dec 2024
FY 2025
Dec 2025
Revenue398.63M424.55M445.58M331.53M258.62M
Cost of Revenue130.03M143.93M148.9M111.65M160.42M
Gross Profit268.61M280.63M296.68M219.88M98.2M
Gross Margin67.4%66.1%66.6%66.3%38.0%
Research & Development00000
Selling, General & Admin177.58M198.21M151.73M151.12M119.23M
Operating Expenses191.25M245.69M229.57M158.24M50.72M
Depreciation & Amortization26.77M20.76M21.54M19.37M11.94M
EBITDA103.4M51.15M72.43M82.57M59.41M
EBITDA Margin25.9%12.0%16.3%24.9%23.0%
Operating Income77.36M34.94M67.11M61.64M47.47M
Operating Margin19.4%8.2%15.1%18.6%18.4%
Interest Income76K8.54M717K1.87M2.24M
Interest Expense25.74M12.89M16.5M12.09M3.59M
Other Income / Expenses(26.47M)(17.44M)(14.27M)(10.53M)(7.19M)
Income Before Tax50.89M17.5M52.32M51.11M40.28M
Pre-Tax Margin12.8%4.1%11.7%15.4%15.6%
Income Tax Expense4.4M5.21M8.33M(5.69M)5.06M
Net Income15.5M(4.41M)18.5M73.49M21.08M
Net Margin3.9%-1.0%4.2%22.2%8.2%
EPS (Basic)1.500.420.731.031.09
EPS (Diluted)1.490.420.731.031.09
Weighted Avg Shares31.09M29.37M25.35M18.5M19.48M
Weighted Avg Shares (Diluted)31.13M29.37M25.25M24M19.48M

Medical Facilities Corporation

TSX:DR.TO

Intrinsic Alpha fair value

Locked

Current Price

$17.42

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.